Subscribe for the Newsletter

Mobile Navigation

Predicting Contamination Before It Happens: Simulation in Sterile Manufacturing

Predicting Contamination Before It Happens: Simulation in Sterile Manufacturing

Mar 26, 2026PAO-03-26-PA-16

Key Takeaways

  • Sterility must be engineered into pharmaceutical facilities. Regulatory frameworks, such as EU GMP Annex 1, emphasize that contamination prevention depends primarily on facility design and contamination control strategies rather than finished-product testing.

  • Cleanrooms behave as dynamic airflow systems. Airflow patterns, particle sources, ventilation design, and human activity interact continuously to influence contamination risk within sterile manufacturing environments.

  • Computational fluid dynamics (CFD) enables predictive cleanroom analysis. CFD simulations allow engineers to model airflow behavior and particle transport in controlled environments, identifying contamination pathways before facilities are constructed or modified.

  • Simulation supports contamination control strategies. Modeling tools can complement environmental monitoring by helping engineers evaluate how facility layout, ventilation systems, and operational disturbances affect contamination risk.

  • Digital twins represent the next stage of simulation-driven facility design. Although still emerging in pharmaceutical manufacturing, digital twins could eventually integrate simulation models with operational data to create continuously evolving digital representations of sterile facilities.

Sterility Must Be Designed, Not Tested

Sterile drug manufacturing differs from many other forms of pharmaceutical production because the consequences of contamination cannot always be detected through finished-product testing. Once a product has been filled and sealed under aseptic conditions, sterility assurance depends heavily on the integrity of the manufacturing environment and the processes used to produce it. Regulatory guidance therefore emphasizes prevention rather than detection. The European Union’s Good Manufacturing Practice (GMP) Annex 1, which governs the manufacture of sterile medicinal products, states explicitly that monitoring or testing alone does not provide assurance of sterility, underscoring the importance of designing manufacturing systems that minimize contamination risk from the outset.1

In the revised Annex 1 framework, sterility assurance is addressed through the concept of a contamination control strategy (CCS): a comprehensive approach that evaluates and manages contamination risks across the entire manufacturing environment. Rather than treating environmental monitoring, facility design, equipment configuration, and personnel practices as separate compliance elements, the CCS integrates them into a single risk-management system. This approach reflects the recognition that contamination risk emerges from the interaction of multiple factors, including airflow patterns, material movement, operator activity, and equipment layout.1

As sterile manufacturing operations grow more complex, particularly in biologics, advanced therapies, and highly automated aseptic filling systems, the engineering challenge of designing and maintaining these controlled environments has intensified. Cleanrooms and aseptic processing areas behave as dynamic systems in which airflow, particle sources, and operational disturbances interact to shape contamination risk. Understanding these interactions has therefore become an increasingly important component of facility design.

One class of tools gaining attention in this context is computational modeling, particularly computational fluid dynamics (CFD) simulations that analyze airflow and particle transport in controlled environments. These simulation approaches allow engineers to evaluate ventilation strategies, airflow patterns, and contamination pathways before facilities are constructed or modified. In parallel, the broader concept of digital twins — virtual representations of physical systems that replicate system behavior — has emerged within Industry 4.0 manufacturing frameworks as a way to link simulation models with operational data.2

Although comprehensive digital twin implementations remain relatively limited in pharmaceutical manufacturing, the underlying modeling approaches are increasingly relevant to sterile facility engineering. By enabling engineers to analyze how airflow patterns, particle transport, and operational disturbances interact within controlled environments, simulation tools offer a potential pathway toward more predictive and resilient facility design. In this way, modeling approaches are beginning to complement traditional CCS by providing new ways to evaluate and manage contamination risk before it manifests in production environments.2

The Engineering Complexity of Sterile Manufacturing Environments

Sterile manufacturing environments are designed to minimize the presence and movement of particles that could compromise product sterility. Achieving this objective requires careful control of airflow, pressure gradients, filtration, and personnel practices within cleanrooms and aseptic processing areas. In practice, however, these environments are highly dynamic. Multiple sources of particle generation and airflow disturbance interact continuously, creating complex patterns of contaminant transport that must be managed through engineering controls.

Research on cleanroom environments has shown that particle concentration and distribution depend on several interacting factors, including emission sources within the room, ventilation configuration, and the location of air-supply outlets and return vents. Computational modeling studies have demonstrated that airflow patterns and ventilation parameters can significantly influence how particles disperse and accumulate within controlled environments.3,4 These findings illustrate that contamination risk cannot be understood solely by considering particle sources; it must also account for the airflow structures that transport those particles through the space.

Human activity introduces another layer of complexity. Operators, materials, and equipment are potential sources of particle, but human movement can also disrupt otherwise stable airflow patterns. Simulation studies examining airflow disturbances in cleanrooms have shown that motion within controlled environments can alter local airflow structures and affect contaminant removal efficiency.5 In sterile manufacturing operations, where personnel must perform manipulations within carefully controlled airflow zones, these disturbances can influence how particles move through critical areas.

Because these factors interact in complex ways, sterile environments behave less like static spaces and more like dynamic fluid systems. Airflow turbulence, particle generation, and environmental disturbances combine to create contamination pathways that may not be immediately visible through conventional monitoring methods. Understanding these dynamics has therefore become a key challenge in sterile facility design, prompting increased interest in analytical approaches that can model airflow behavior and particle transport within controlled environments.

Computational modeling methods, particularly CFD, have emerged as valuable tools for analyzing these systems. By simulating airflow and particle trajectories within a virtual representation of the facility, engineers can evaluate how design decisions influence contamination risk. This ability to analyze the behavior of sterile environments before physical implementation forms the basis for the modeling approaches discussed in the following sections.3,6

Why Simulation Has Become Essential in Cleanroom Engineering

Because sterile manufacturing environments behave as complex airflow systems, engineers have increasingly turned to computational modeling tools to analyze and optimize their performance. Among these tools, CFD has become one of the most widely used approaches for studying airflow and contaminant transport in controlled environments.

In cleanroom engineering research, CFD models are commonly used to calculate airflow distribution, pressure gradients, and particle trajectories within enclosed spaces. These models solve the governing equations of fluid motion to estimate how air flows through ventilation systems and across work areas, enabling detailed analysis of the environmental conditions that influence contamination risk. Studies applying CFD to cleanroom environments have demonstrated that airflow speed, ventilation configuration, and spatial layout can significantly influence the distribution of particles throughout the room.3

One advantage of CFD-based simulation is that it allows engineers to evaluate environmental behavior before a facility has been constructed or modified. By creating a virtual model of a cleanroom or aseptic processing area, designers can test different ventilation configurations, airflow strategies, or equipment layouts to understand how these choices affect airflow stability and contaminant transport. Systematic reviews of cleanroom CFD research have highlighted the growing use of these simulations in engineering analysis, particularly for evaluating turbulence models, particle-tracking methods, and ventilation performance in controlled environments.6

Simulation tools also provide a way to explore environmental scenarios that would be difficult or impractical to test experimentally. For example, CFD models can simulate the impact of airflow disturbances, changes in ventilation configuration, or variations in emission sources across the facility. By analyzing these conditions in a virtual environment, engineers can identify potential contamination pathways and evaluate mitigation strategies without interrupting production operations.

For sterile manufacturing facilities, where modifications to ventilation systems or room layouts can be costly and disruptive, this predictive capability is particularly valuable. Simulation-based analysis enables engineers to evaluate the environmental implications of design decisions during the planning phase, helping ensure that airflow control strategies and facility layouts support contamination control objectives from the outset.

Modeling Airflow and Particle Transport in Cleanrooms

Once engineers adopt computational modeling approaches, the next question becomes how these simulations represent airflow and contaminant transport inside cleanrooms. In cleanroom simulations, airflow is typically represented through numerical solutions of the fluid-motion equations that govern pressure, velocity, and turbulence within the space. These calculations allow engineers to visualize airflow trajectories and identify regions where air circulation may be disrupted by equipment, walls, or ventilation components. By mapping these airflow patterns, CFD models can reveal how particles may be transported through the environment and where they may accumulate.3

Particle transport modeling is an important extension of these airflow simulations. Once airflow structures are established within the model, particle-tracking methods can estimate how contaminants released from emission sources might disperse through the room. These simulations can account for factors such as airflow velocity, turbulence intensity, and particle characteristics, allowing engineers to analyze potential contamination pathways within the cleanroom environment. Research applying CFD to controlled environments has shown that airflow configuration, emission sources, and ventilation parameters all influence particle distribution patterns.4

Because CFD models rely on mathematical representations of physical systems, their reliability depends on how well those models capture real-world behavior. For this reason, many simulation studies compare model predictions with experimental measurements of airflow or particle concentration. Such validation efforts help confirm that the simulated airflow structures and particle trajectories correspond to observed environmental conditions. Studies examining particulate behavior in indoor environments have used these comparisons to evaluate how accurately CFD models reproduce particle dispersion patterns under controlled conditions.4

Through this combination of airflow modeling and particle-transport analysis, CFD simulations provide a way to examine contamination dynamics that are difficult to observe directly in operating cleanrooms. By visualizing how airflow carries particles through the environment, engineers can identify locations where contaminants may accumulate or where airflow disturbances may create unintended transport pathways. These insights are particularly useful when evaluating ventilation strategies and environmental controls designed to protect critical sterile processing zones.

Simulation of Ventilation and Critical-Zone Protection

Within sterile manufacturing environments, one of the primary objectives of ventilation design is to maintain stable airflow patterns that protect critical processing zones. These zones, such as filling needles, open containers, or other exposed sterile surfaces, must remain within controlled airflow conditions that minimize the introduction and transport of particles. Ventilation systems therefore play a central role in contamination control, shaping how air moves through the cleanroom and how potential contaminants are carried away from sensitive areas.

Computational modeling studies examining controlled environments have demonstrated that ventilation configuration can significantly influence airflow behavior. In clean environments designed for surgical or sterile processing activities, airflow distribution and ventilation efficiency are closely tied to the design of air-supply systems and the spatial layout of the room. Studies evaluating ultra-clean ventilation environments have shown that airflow patterns created by ventilation systems affect how particles move through the space and how effectively contaminants are removed from the environment.7

Laminar airflow systems represent one commonly used strategy for protecting critical zones in controlled environments. These systems are designed to create relatively uniform airflow moving in a consistent direction, reducing turbulence and limiting the recirculation of particles near sterile work areas. Computational simulations of ventilation systems in controlled environments have been used to analyze how airflow velocity, temperature distribution, and ventilation layout influence the stability of these airflow patterns. This modeling allows engineers to assess whether ventilation designs provide adequate environmental protection for critical processing areas.8

Simulation tools are particularly useful for identifying how room geometry and ventilation design interact to shape airflow behavior around sensitive zones. Changes in ventilation configuration, equipment placement, or room layout can alter airflow trajectories in ways that affect contamination risk. By analyzing these interactions within a computational model, engineers can evaluate how different design choices influence airflow stability and contaminant removal before implementing changes in a physical facility.

Modeling Aseptic Processing Environments

While cleanroom airflow modeling often focuses on general ventilation behavior within controlled spaces, aseptic processing environments introduce additional design considerations. In these settings, environmental control must support both contamination prevention and the operational requirements of sterile manufacturing processes. Equipment placement, personnel movement, and process workflows can all influence airflow behavior, creating localized disturbances that may affect contamination transport within the facility.

Modeling approaches that incorporate air-mass balance analysis provide one way to evaluate these interactions. In controlled environments used for advanced manufacturing processes, airflow modeling has been used to examine how ventilation strategies influence the distribution of air and potential contaminants within processing areas. These studies analyze the balance between air supply and exhaust flows to understand how ventilation systems maintain stable environmental conditions across different zones of the facility.9

Modeling approaches allow engineers to examine how airflow structures interact with operational conditions inside aseptic processing areas. Because these environments contain multiple potential particle sources, including operators, materials, and equipment, understanding how airflow carries contaminants through the space is essential for effective contamination control. Simulation tools can therefore help evaluate how different ventilation strategies influence airflow stability and contaminant removal under various operating scenarios.

More broadly, systematic reviews of cleanroom CFD research highlight how simulation methods have been applied to analyze ventilation performance, particle transport, and environmental stability across a range of controlled environments. These studies describe the growing role of computational modeling in engineering analysis of cleanroom systems, including the use of turbulence models and particle-tracking techniques to examine airflow behavior and contamination dynamics.6

By applying these analytical tools during facility design or modification, engineers can explore how ventilation strategies and operational configurations influence environmental performance. This capability allows modeling approaches to complement traditional engineering methods, providing additional insight into how airflow behavior and particle transport may affect contamination risk in aseptic manufacturing environments.

From Simulation Models to Digital Twins

CFD and other simulation methods used in cleanroom engineering are typically applied as analytical tools during facility design or troubleshooting. Engineers build a virtual representation of the physical environment, simulate airflow behavior under specific conditions, and analyze how particles or contaminants may move through the system. These models provide valuable insight into environmental dynamics, but they generally represent static simulations rather than continuously evolving representations of a real facility.

The concept of a digital twin extends this modeling approach by creating a virtual representation of a physical system that reflects its behavior and operational characteristics. In manufacturing contexts, digital twins are typically described as virtual constructs that replicate the behavior of physical assets or processes. These systems combine a physical environment, a digital model representing that environment, and communication pathways that allow information to flow between the two.2

Within pharmaceutical manufacturing, digital twins are being explored as part of broader Industry 4.0 initiatives aimed at integrating data, modeling, and automation across production systems. In this framework, simulation models, such as those used to analyze airflow or particle transport, can form the analytical foundation for digital representations of manufacturing environments. By linking these models with operational data, a digital twin could theoretically provide a continuously updated representation of facility conditions and system behavior.2

At present, however, full digital-twin implementations remain relatively limited within pharmaceutical manufacturing. Although the concept has gained attention as part of digital manufacturing strategies, most applications described in the literature remain at the level of modeling frameworks or early-stage implementations. For this reason, the modeling approaches discussed in earlier sections, such as CFD simulations of airflow and particle transport, are best understood as foundational analytical tools that could eventually contribute to more integrated digital representations of sterile manufacturing environments.2

The Current Maturity of Digital Twins in Pharmaceutical Manufacturing

Although the concept of digital twins has attracted growing attention across many manufacturing industries, its application within pharmaceutical production remains at an early stage. The idea of creating a digital representation of a manufacturing system capable of reflecting physical behavior and supporting simulation-based analysis aligns closely with the broader Industry 4.0 vision of data-driven manufacturing. In this context, digital twins are often discussed as tools that could integrate modeling, monitoring, and operational data within a unified digital environment.

In practice, however, the implementation of fully developed digital twins in pharmaceutical manufacturing has been limited. Reviews of digital-twin research in the pharmaceutical and biopharmaceutical sectors note that most published work focuses on conceptual frameworks, modeling approaches, or early-stage demonstrations rather than complete operational systems. While simulation tools and process models are widely used in engineering analysis, the integration of those models with real-time manufacturing data to create continuously updating digital representations remains relatively uncommon in the industry.2

Several factors contribute to this limited adoption. Pharma manufacturing systems operate within strict regulatory frameworks that emphasize validated processes, documented controls, and rigorous change management. Introducing new digital infrastructure capable of linking modeling environments with operational systems therefore requires careful consideration of validation, data integrity, and system governance. As a result, many organizations continue to use simulation tools primarily for engineering analysis during facility design, process development, or troubleshooting rather than as continuously connected operational systems.

Despite these challenges, the underlying modeling approaches discussed earlier, such as airflow simulations and particle transport analysis, demonstrate how digital representations of physical environments can provide valuable engineering insight. As modeling tools, data infrastructure, and digital manufacturing technologies continue to evolve, these analytical capabilities may form part of broader digital frameworks for analyzing and managing complex pharmaceutical manufacturing systems.

Bridging Simulation and Contamination Control Strategy

The increasing use of simulation tools in cleanroom engineering has implications beyond facility design. In modern sterile manufacturing frameworks, contamination control is addressed through integrated strategies that evaluate risks across the entire production environment. The CCS required under EU GMP Annex 1 reflects this system-level perspective, requiring manufacturers to consider how facility design, equipment configuration, personnel practices, and environmental monitoring interact to influence contamination risk.1

Simulation-based analysis can contribute to this integrated approach by providing a way to evaluate environmental behavior during the design phase of sterile facilities. Computational models allow engineers to explore how airflow structures, particle transport mechanisms, and ventilation configurations influence contamination pathways within controlled environments. By examining these interactions within a virtual model of the facility, designers can identify areas where airflow disturbances or equipment placement might create unintended contamination risks.

This capability is particularly valuable when considering how environmental conditions change under operational disturbances. Activities like operator movement, material transfers, and equipment operation can alter airflow patterns and affect contaminant transport within the room. Simulation studies have demonstrated how airflow disturbances and ventilation design influence particle distribution and contaminant removal efficiency in controlled environments, highlighting the importance of understanding these dynamics during facility planning.6

By incorporating modeling approaches into engineering analysis, manufacturers can complement traditional contamination-control practices with predictive evaluation of environmental behavior. While these simulations do not replace environmental monitoring or validation activities, they can provide additional insight into how facility design decisions influence contamination risk. In this way, modeling tools may help support the risk-based engineering assessments that underpin modern contamination control strategies in sterile manufacturing environments.

Conclusion — Designing Sterile Facilities for Predictability

Sterile pharmaceutical manufacturing has traditionally relied on a combination of engineering controls, environmental monitoring, and operational discipline to manage contamination risk. While these elements remain fundamental, the increasing complexity of modern sterile production, particularly in biologics, advanced therapies, and highly automated filling operations, has made it progressively more difficult to rely solely on empirical observation and post-implementation validation. As facilities grow larger and more technically sophisticated, the ability to anticipate environmental behavior before construction or modification becomes increasingly valuable.

Simulation technologies are beginning to shift how engineers approach this challenge. By allowing airflow dynamics, particle transport, and ventilation performance to be examined within virtual environments, computational modeling introduces a more predictive dimension to sterile facility design. Instead of relying primarily on iterative adjustments after a facility is built, engineers can explore potential contamination pathways during the design phase, testing how changes in layout, ventilation configuration, or operational conditions may influence environmental stability.

In this sense, modeling tools represent more than an additional engineering technique — they signal a gradual shift toward predictive contamination control. The ability to simulate environmental behavior before it occurs allows manufacturers to evaluate risk in ways that traditional monitoring methods cannot, providing new insight into how facility design decisions influence contamination dynamics.

As digital infrastructure within pharmaceutical manufacturing continues to mature, these simulation approaches may increasingly connect with broader digital-manufacturing frameworks. Concepts like digital twins suggest the possibility of linking physical facilities with continuously evolving digital representations capable of analyzing system behavior in near real time. While such systems remain at an early stage in pharmaceutical manufacturing, the analytical foundations already exist in the airflow and particle modeling tools used today.

Ultimately, the growing use of simulation in cleanroom engineering reflects a broader evolution in sterile manufacturing philosophy. Rather than treating contamination control as a problem addressed primarily through monitoring and response, manufacturers are beginning to approach it as a system that can be analyzed, predicted, and engineered for stability before production begins. As modeling tools and digital manufacturing capabilities continue to advance, this predictive approach may play an increasingly central role in how sterile facilities are designed, optimized, and operated.

.

References

1. EU GMP Annex 1: Manufacture of Sterile Medicinal Products. European Commission. 22 Aug. 2022.

2. Chen, Yingjie, et al. (2020). “Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review.” Processes. 8: 1088 (2020).

3. Mičko, Pavol, et al.Impact of the Speed of Airflow in a Cleanroom on the Degree of Air Pollution.Applied Sciences. 12:2466 (2022).

4. Çoşgun, Ahmet, and Onur Gündüztepe. CFD-Based Lagrangian Multiphase Analysis of Particulate Matter Transport in an Operating Room Environment.Processes. 13: 2507 (2025).

5. Guldana, Abiyeva, et al. “Impact of Airflow Disturbance from Human Motion on Contaminant Control in Cleanroom Environments: A CFD-Based Analysis.” Builldings. 15: 2264 (2025). https://www.mdpi.com/2075-5309/15/13/2264

6. Puntigam, Stephan, Stefan Radl, and Peter Karlinger. “Considerations for Computational Fluid Dynamics Studies of Cleanrooms Exceeding Classical Indoor Air Simulations: A Systematic Review.” Indoor Air. 2025: 4302921 (2025).

7. Duque-Daza, Carlos A, et al. Analysis of the airflow features and ventilation efficiency of an Ultra-Clean-Air operating theatre by qDNS simulations and experimental validation.” Build. Environ. 256: 1114444 (2024).

8. Krishnankutty, Vikas Valsala, Chandrasekharan Muraleedharan, and Arun Palatel. Numerical Analysis of Airflow and Temperature Distribution in Surgical Operating Rooms.” Buildings. 16: 171 (2025).

9. Furomitsu, Shunpei, Manabu Mizutani, and Masahiro Kino-oka. Approach of design for air mass balance in an aseptic processing area for cell-based products.Regen. Ther. 28: 20–29 (2024).

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.